Trovagene Announces Positive Response to Treatment in Phase 1b/2 Trial of Onvansertib in Patients with KRAS-Mutated Metastatic Colorectal Cancer

Stock Information for TrovaGene Inc.

Loading

Please wait while we load your information from QuoteMedia.